Philippines
Hepatitis B
Download HBV dataHBV National Action Plan
Outdated
HBV elimination goal
HBV testing policy
Universal
HepB birth dose policy
Yes
HBV mother to child transmission elimination goal
Adopted
Recommendations for HBV testing of pregnant women
Adopted
Year of birth dose introduction
2006
Eligible for HBV generic medicines
Estimates of economic burden
Not Adopted
Licensed point-of-care PCR testing to detect HBV
Adopted
National treatment guidelines exist
Adopted
No patient co-pays for HBsAg testing
Not Adopted
Simplified care: No treatment co-pays
Not Adopted
Simplified care: Simplified treatment and monitoring algorithm for primary care providers
Adopted
Adult HBV vaccination policy for high-risk populations
Adopted
Routine official reports to monitor mortality
Not Adopted
Routine official reports to monitor incidence
Not Adopted
National prevalence survey within the last 5 years
Not Adopted
System for monitoring testing and treatment
Not Adopted
Public budget line for testing and treatment
Not Adopted
HCV National Action Plan
Outdated
HCV elimination goal
HCV testing policy
Risk-based
Eligible for HCV generic medicines
National treatment guidelines exist
Adopted
No fibrosis restrictions
Adopted
No sobriety restrictions
Not Adopted
No genotyping
Simplified care: Less than 2 clinic visits during treatment
Partially Adopted
Simplified care: Non-specialists can prescribe treatment
Adopted
Simplified care: No treatment co-pays
Not Adopted
Licensed point-of-care PCR testing to detect HCV
Adopted
No patient co-pays for anti-HCV testing
Not Adopted
Registration of originator HCV DAAs
Adopted
Registration of generic HCV DAAs
Adopted
National policy for harm reduction for persons who inject drugs
Not Adopted
Routine official reports to monitor incidence
Not Adopted
National policy for syringe exchange in federal prisons
Not Adopted
Decriminalization of possession of syringes and paraphernalia
Not Adopted
Routine official reports to monitor mortality
Not Adopted
National prevalence survey within the last 5 years
Not Adopted
Estimates of economic burden
Not Adopted
System for monitoring testing and treatment
Not Adopted
Public budget line for testing and treatment
Not Adopted
Hepatitis C
Download HCV dataHBV National Action Plan
Outdated
HBV elimination goal
HBV testing policy
Universal
HepB birth dose policy
Yes
HBV mother to child transmission elimination goal
Adopted
Recommendations for HBV testing of pregnant women
Adopted
Year of birth dose introduction
2006
Eligible for HBV generic medicines
Estimates of economic burden
Not Adopted
Licensed point-of-care PCR testing to detect HBV
Adopted
National treatment guidelines exist
Adopted
No patient co-pays for HBsAg testing
Not Adopted
Simplified care: No treatment co-pays
Not Adopted
Simplified care: Simplified treatment and monitoring algorithm for primary care providers
Adopted
Adult HBV vaccination policy for high-risk populations
Adopted
Routine official reports to monitor mortality
Not Adopted
Routine official reports to monitor incidence
Not Adopted
National prevalence survey within the last 5 years
Not Adopted
System for monitoring testing and treatment
Not Adopted
Public budget line for testing and treatment
Not Adopted
HCV National Action Plan
Outdated
HCV elimination goal
HCV testing policy
Risk-based
Eligible for HCV generic medicines
National treatment guidelines exist
Adopted
No fibrosis restrictions
Adopted
No sobriety restrictions
Not Adopted
No genotyping
Simplified care: Less than 2 clinic visits during treatment
Partially Adopted
Simplified care: Non-specialists can prescribe treatment
Adopted
Simplified care: No treatment co-pays
Not Adopted
Licensed point-of-care PCR testing to detect HCV
Adopted
No patient co-pays for anti-HCV testing
Not Adopted
Registration of originator HCV DAAs
Adopted
Registration of generic HCV DAAs
Adopted
National policy for harm reduction for persons who inject drugs
Not Adopted
Routine official reports to monitor incidence
Not Adopted
National policy for syringe exchange in federal prisons
Not Adopted
Decriminalization of possession of syringes and paraphernalia
Not Adopted
Routine official reports to monitor mortality
Not Adopted
National prevalence survey within the last 5 years
Not Adopted
Estimates of economic burden
Not Adopted
System for monitoring testing and treatment
Not Adopted
Public budget line for testing and treatment
Not Adopted
Overview
HBV elimination goal
HCV elimination goal
Prevalence (national)
Modelled
Survey/surveillance
No data available
Hepatitis related deaths (national)
Modelled
HBV
6,057
2019
(4,764 - 7,660)
IHME, GBD 2019 (accessed 2022)
Survey/surveillance
No data available
HBV chart
Modelled
HCV
5,110
2019
(4,061 - 6,445)
IHME, GBD 2019 (accessed 2022)
Survey/surveillance
No data available
HCV chart
No. of syringes/PWID/year
Survey/surveillance
HCV
0
2015
(0 - 0)
HIV And AIDS Data Hub for Asia-Pacific, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines
